APA (7th ed.) Citation

ZA, Y., Ş, Y., EM, S., A, Ş., P, U. G., ZN, Ö., . . . M, Y. (2025). Day + 100 bone marrow megakaryocyte count predicts transplant outcome in patients with high-risk myelodysplastic syndrome and acute leukemia. Journal of hematopathology, 18(1), 18. https://doi.org/10.1007/s12308-025-00633-x

Chicago Style (17th ed.) Citation

ZA, Yegin, Yıldız Ş, Savaş EM, Şeker A, Uyar Göçün P, Özkurt ZN, Akyürek N, and Yağcı M. "Day + 100 Bone Marrow Megakaryocyte Count Predicts Transplant Outcome in Patients with High-risk Myelodysplastic Syndrome and Acute Leukemia." Journal of Hematopathology 18, no. 1 (2025): 18. https://doi.org/10.1007/s12308-025-00633-x.

MLA (9th ed.) Citation

ZA, Yegin, et al. "Day + 100 Bone Marrow Megakaryocyte Count Predicts Transplant Outcome in Patients with High-risk Myelodysplastic Syndrome and Acute Leukemia." Journal of Hematopathology, vol. 18, no. 1, 2025, p. 18, https://doi.org/10.1007/s12308-025-00633-x.